Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice.

Anson M, Crain-Denoyelle AM, Baud V, Chereau F, Gougelet A, Terris B, Yamagoe S, Colnot S, Viguier M, Perret C, Couty JP.

J Clin Invest. 2012 Feb;122(2):586-99. doi: 10.1172/JCI43937. Epub 2012 Jan 17.

2.

Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling.

Zhang Y, Wei W, Cheng N, Wang K, Li B, Jiang X, Sun S.

Hepatology. 2012 Nov;56(5):1631-40. doi: 10.1002/hep.25849. Epub 2012 Oct 9.

PMID:
22610915
3.

Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.

Ovejero C, Cavard C, Périanin A, Hakvoort T, Vermeulen J, Godard C, Fabre M, Chafey P, Suzuki K, Romagnolo B, Yamagoe S, Perret C.

Hepatology. 2004 Jul;40(1):167-76.

PMID:
15239100
4.

Role of leukocyte cell-derived chemotaxin 2 as a biomarker in hepatocellular carcinoma.

Okabe H, Delgado E, Lee JM, Yang J, Kinoshita H, Hayashi H, Tsung A, Behari J, Beppu T, Baba H, Monga SP.

PLoS One. 2014 Jun 3;9(6):e98817. doi: 10.1371/journal.pone.0098817. eCollection 2014.

5.

The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling.

Trierweiler C, Blum HE, Hasselblatt P.

PLoS One. 2012;7(7):e40638. doi: 10.1371/journal.pone.0040638. Epub 2012 Jul 6.

6.

Wnt/beta-catenin signaling activates and determines hepatic zonal expression of glutathione S-transferases in mouse liver.

Giera S, Braeuning A, Köhle C, Bursch W, Metzger U, Buchmann A, Schwarz M.

Toxicol Sci. 2010 May;115(1):22-33. doi: 10.1093/toxsci/kfq033. Epub 2010 Jan 30.

PMID:
20118494
7.

Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.

Du Q, Zhang X, Cardinal J, Cao Z, Guo Z, Shao L, Geller DA.

Cancer Res. 2009 May 1;69(9):3764-71. doi: 10.1158/0008-5472.CAN-09-0014. Epub 2009 Apr 21.

8.
9.

DKK1 promotes hepatocellular carcinoma cell migration and invasion through β-catenin/MMP7 signaling pathway.

Chen L, Li M, Li Q, Wang CJ, Xie SQ.

Mol Cancer. 2013 Dec 10;12:157. doi: 10.1186/1476-4598-12-157.

10.

ASC-associated inflammation promotes cecal tumorigenesis in aryl hydrocarbon receptor-deficient mice.

Ikuta T, Kobayashi Y, Kitazawa M, Shiizaki K, Itano N, Noda T, Pettersson S, Poellinger L, Fujii-Kuriyama Y, Taniguchi S, Kawajiri K.

Carcinogenesis. 2013 Jul;34(7):1620-7. doi: 10.1093/carcin/bgt083. Epub 2013 Mar 1.

PMID:
23455376
11.
12.

APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.

Janssen KP, Alberici P, Fsihi H, Gaspar C, Breukel C, Franken P, Rosty C, Abal M, El Marjou F, Smits R, Louvard D, Fodde R, Robine S.

Gastroenterology. 2006 Oct;131(4):1096-109. Epub 2006 Aug 16. Erratum in: Gastroenterology. 2006 Dec;131(6):2029.

PMID:
17030180
13.

Diverse Basis of β-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis.

Okabe H, Kinoshita H, Imai K, Nakagawa S, Higashi T, Arima K, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Ishiko T, Yoshizumi T, Beppu T, Monga SP, Baba H, Maehara Y.

PLoS One. 2016 Apr 21;11(4):e0152695. doi: 10.1371/journal.pone.0152695. eCollection 2016.

14.

Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.

Evason KJ, Francisco MT, Juric V, Balakrishnan S, Lopez Pazmino Mdel P, Gordan JD, Kakar S, Spitsbergen J, Goga A, Stainier DY.

PLoS Genet. 2015 Jul 2;11(7):e1005305. doi: 10.1371/journal.pgen.1005305. eCollection 2015 Jul.

15.

Global increase of p16INK4a in APC-deficient mouse liver drives clonal growth of p16INK4a-negative tumors.

Ueberham E, Glöckner P, Göhler C, Straub BK, Teupser D, Schönig K, Braeuning A, Höhn AK, Jerchow B, Birchmeier W, Gaunitz F, Arendt T, Sansom O, Gebhardt R, Ueberham U.

Mol Cancer Res. 2015 Feb;13(2):239-49. doi: 10.1158/1541-7786.MCR-14-0278-T. Epub 2014 Sep 30.

16.

NKD1 marks intestinal and liver tumors linked to aberrant Wnt signaling.

Stancikova J, Krausova M, Kolar M, Fafilek B, Svec J, Sedlacek R, Neroldova M, Dobes J, Horazna M, Janeckova L, Vojtechova M, Oliverius M, Jirsa M, Korinek V.

Cell Signal. 2015 Feb;27(2):245-56. doi: 10.1016/j.cellsig.2014.11.008. Epub 2014 Nov 14.

17.

The transforming growth factor-α and cyclin D1 genes are direct targets of β-catenin signaling in hepatocyte proliferation.

Torre C, Benhamouche S, Mitchell C, Godard C, Veber P, Letourneur F, Cagnard N, Jacques S, Finzi L, Perret C, Colnot S.

J Hepatol. 2011 Jul;55(1):86-95. doi: 10.1016/j.jhep.2010.10.021. Epub 2010 Nov 30.

PMID:
21145869
18.

Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.

Qin X, Zhang H, Zhou X, Wang C, Zhang H, Zhang X, Ye L.

Transl Res. 2007 Nov;150(5):281-94. Epub 2007 Jul 18.

PMID:
17964517
19.

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas.

de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8847-51.

20.

Zinc finger transcription factor 191, directly binding to β-catenin promoter, promotes cell proliferation of hepatocellular carcinoma.

Liu G, Jiang S, Wang C, Jiang W, Liu Z, Liu C, Saiyin H, Yang X, Shen S, Jiang D, Zhou P, Han D, Hu X, Yi Q, Yu L.

Hepatology. 2012 Jun;55(6):1830-9. doi: 10.1002/hep.25564.

PMID:
22213192

Supplemental Content

Support Center